Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly

Citation
B. Gutt et al., Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly, EUR J ENDOC, 144(2), 2001, pp. 109-116
Citations number
33
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EUROPEAN JOURNAL OF ENDOCRINOLOGY
ISSN journal
08044643 → ACNP
Volume
144
Issue
2
Year of publication
2001
Pages
109 - 116
Database
ISI
SICI code
0804-4643(200102)144:2<109:CPIIEI>2.0.ZU;2-E
Abstract
Objective: For patients in whom acromegaly persists despite pituitary surge ry, conventional pituitary irradiation represents an additional treatment o ption. A 30-60% cure rate is described in the literature, but these studies did not utilise strict rules of remission, such as 'safe' GH levels <2.5 < mu>g/l, and age-adjusted normal IGF-I levels. Design and methods: We report the outcome of 41 patients with acromegaly wh o received pituitary conventional external irradiation. The median follow-u p time was 12.8 years (3.7-43.4 years) post-radiotherapy. Results: The median pre-irradiation GH level was 31.0 mug/l (7.0-210 mug/l) . Information on IGF-I levels was only available for 6 patients prior to th erapy. Utilising strict rules of remission, one-third (14/41) of our patien ts had normal biochemical parameters, i,e. 'safe' GH (0.5 mug/l (range 0.2- 1.6 mug/l)) and normal age-adjusted IGF-I levels (multiple of upper limit o f normal range (xULN): 0.45 (0.2-1.0)) at the end of the follow-up period. An additional 9 patients achieved normal levels with adjunctive drug therap y. Furthermore, disease activity was reduced in a considerable proportion o f the 18 patients who did not achieve normal biochemical levels (CH: 3.6 mu g/l (1.9-15.7 mug/l): xULN of IGF-I: 1.6 (0.9-2.6)), In retrospect, remissi on is unlikely in patients who had a GH level greater than 52 mug/l (mean+2 S.D. of cured patients) prior to radiotherapy. In addition to the 12 patients with pre-irradiation pituitary functional de ficiency, another 11 patients developed symptoms of panhypopituitarism duri ng the 3-year period following irradiation. Within a 6-year period. partial pituitary insufficiency was observed in a further 7 patients, thus necessi tating hormone substitution treatment. Conclusion: Using strict rules of remission, in our cohort we found both a normalisation of IGF-I and safe GH levels in 34%, of patients treated for a cromegaly with conventional irradiation therapy.